P rimary pulmonary hypertension (PPH) is a form of severe pulmonary hypertension (PH) of unknown etiology within a group of pulmonary hypertensive diseases of which some of the risk factors are known. [1] [2] [3] PPH is characterized by unique lesions of the small precapillary pulmonary arterioles, thickening of the vascular wall (medial hypertrophy), and lumen obliteration by endothelial cell proliferation 4, 5 or in situ thrombosis. 6 Either vasoconstriction or the impediment of blood flow by these lesions causes the pulmonary artery pressure to rise.
A genetic predisposition is most certainly required for the development of severe PH because (1) the background incidence of PPH in the general population is very small; (2) PPH is familial (FPPH) in Ϸ6% of the cases; and (3) the incidence in known at-risk populations-for example, in patients infected with the AIDS virus or in women who have been treated with appetite-suppressant drugs-is also very low. 4 -8 Progress in understanding the pathobiology of severe pulmonary hypertensive diseases has been hampered by 2 vexing major problems. First, there continues to be a lack of information regarding the natural history and the development of the critical vascular lesions. Second, there are no animal models that fully replicate the human pulmonary vascular pathology.
Although the pulmonary vascular lesions, in particular the so-called plexiform lesions, have in recent years been better characterized using immune histology and in situ hybridization technology, 5,9,10 much more needs to be learned about the molecular pathology of these complex lesions. Although FPPH has been linked to germline mutations of the bone morphogenic protein (BMP) receptor II (BMPRII), 11, 12 and somatic mutations occur in plexiform lesion endothelial cells in sporadic PPH, 13 it is not clear whether FPPH is molecularly distinct from sporadic, nonfamilial PPH.
The recent availability of gene microarray technology 14 now permits the analysis of the gene expression profile of lung tissue obtained from patients with PPH and the comparison of the gene expression profile in the diseased lungs with that found in normal lung tissue. The output and density of data provided by this approach overcome the limitations of analyses based on the exploration of changes of a single gene at a time. We believe that lung tissue gene expression profiling is useful, because the diseased tissue contains information relevant to the disease process. Our present study was designed to analyze the gene expression pattern using high-quality RNA extracted from lungs of patients with PPH, including 2 patients with FPPH. We wished to address the main question, whether there is a molecular signature that distinguishes lung tissue of PH patients from structurally normal lung tissue. In addition, we questioned whether there is a gene expression pattern that distinguishes the lungs of patients with sporadic PPH from lungs of patients with FPPH. Here we report the significant differences in expressed genes between normal lungs and PPH lungs and the characteristic gene expression pattern that distinguishes PPH from FPPH.
We provide data that illustrate an expression pattern in PPH lungs indicative of an imbalance between genes regulating cell growth and genes regulating apoptosis. We also report that there are alterations in the lung tissues from patients with sporadic PPH in the expression of several genes coding for proteins of the transforming growth factor (TGF)-␤ signaling superfamily. 15 These data suggest that in addition to gene mutations of the BMPRII and TGF-␤ receptor II (TGF-␤RII) genes, [11] [12] [13] there are also changes in the level of expression of related TGF-␤ family genes. 15 
Materials and Methods

Patient Lung Tissue Samples
The lung tissue samples were from patients with PPH and from patients with FPPH (see Table 1 ). The normal lung tissue samples were from 3 women (with the primary diagnosis of cervical carcinoma, adenocarcinoma of the lung, and unknown primary diagnosis) and 3 men (with the primary diagnosis of head trauma, synovial cell carcinoma, and lung carcinoma). These lung tissue samples were carefully inspected by one of us (R.M.T.) and declared histologically normal.
Figure 1.
Histology of a normal lung (A and B) and 2 PPH lungs (C through F) used in the microarray studies. Low-power view of normal and PPH lungs highlights preservation of the overall architecture of lung structure (B indicates bronchiole; V, pulmonary arteries; and AS, air spaces). Normal pulmonary artery is shown in panel B, with progressive tapering of the muscular wall. Both PPH lungs had marked thickening of the vascular media (the size of pulmonary arteries is larger than the accompanying bronchiole). Panel D shows a plexiform lesion (from the patient shown in panel C) with proliferated endothelial cells (large arrow), and the vessel is surrounded by lymphocytes (arrowheads). Lymphocytes are indicated by small arrows. Panel F shows the lumen of a pulmonary artery occluded by myofibroblastic cells (arrow; PPH patient shown in panel E), which are followed by concentric proliferation of endothelial and myofibroblastic cells (arrowheads). Panels A, C, and E: hematoxylin and eosin, ϫ20. Panels B, D, and F: hematoxylin and eosin; B, ϫ40, D and F, ϫ100. Details for RNA preparation, reverse transcription, labeling, hybridization, and data analysis can be found in the online data supplement available at http://www.circresaha.org.
Data Analysis
Detailed protocols for data analysis of Affymetrix microarrays and extensive documentation of the sensitivity and quantitative aspects of the method have been described. 14, 16, 17 Concordant gene expression was established by comparing the expression level (for each gene) in a patient tissue sample with the expression level in 6 normal lung tissue samples. Because there were 6 PH patient samples, this allowed 36 comparisons.
To determine reproducibility of results, we obtained parallel duplicate lung RNA preparations and compared differences in Affymetrix arrays. We found false-positive changes in 1.7% to 3% of all genes analyzed. When all normal lung samples were compared with all diseased lung samples (6ϫ6 or 36 independent comparisons), the average number of genes called changed per comparison was 1099 (18.1%). These data indicate that the changes between normal and diseased tissue gene expression are real differences.
Statistical Analysis
Raw data from array scans were averaged across all gene probes on each array, and a scaling factor was applied to bring the average intensity for all probes on the array to 2500. This allows any sample to be normalized for comparison with any other comparable sample, ie, lung versus lung. We used a paired, 2-tailed t test to assess whether gene expression differences were significant (PϽ0.05).
Results
Total RNA isolated from lung tissue of 6 patients with PPH (2 of whom had FPPH) and 6 patients with histologically normal lung tissue removed during lung surgery was analyzed. The demographic and hemodynamic data are shown in Table 1 . Figure 1 shows characteristic vascular lesions in the lungs of these patients.
Difference in the Number of Genes Expressed in PPH and Normal Lungs
From a total of Ϸ6800 genes assayed, 307 genes were differently expressed (PϽ0.05) when comparison was made between the normal lung tissue RNA (nϭ6) and the PPH lung tissue RNA samples (nϭ6). Of these genes with changed expression, 133 genes showed upregulation and 174 downregulation in PPH. Figure 2 shows a dendogram of the gene expression patterns in the lungs from the 6 patients and the 6 normal lungs. The expression pattern was similar for the 3 sporadic PPH lungs and differed from that of the normal lungs, because the overall gene expression patterns of the normal lungs resembled each other more closely, as did those of the PPH lungs. This can be easily seen from the clustering and abundance of the red and blue bars (higher and lower degrees of gene expression, respectively), in Figure 2 . The lung tissue gene expression pattern of the female patient 6 (Table 1) segregated with the 2 known cases of FPPH. This patient, with extreme pulmonary artery pressure elevation, had been orphaned, and her family history was unknown. Table 2 provides a list of genes with a high degree of concordance in their differential expression (PPH versus normal). The list ranks those genes for which from 25 to 31 of 36 comparisons were directionally concordant, ie, showed increased or decreased expression. The highest concordance was found for the gene coding for the necdin-related protein, which was decreased in PPH (PϽ0.005) (31 of 36 comparisons). The necdin gene codes for a nuclear protein, which is maternally imprinted and interacts with the transcription factor E2F1. Disruption of the mouse necdin gene results in early postnatal lethality. 18 
Analysis of Gene Expression by Cluster Analysis
Comparison between normal lungs (nϭ6), the PPH lungs (nϭ3), and the FPPH patients' lungs (nϭ2) based on cluster analysis showed that there were several clusters of reduced gene expression that characterized PPH patient samples when compared with FPPH patient samples and normal lung samples ( Figure 3 ). Because patient 6 could not be separated from the 2 known cases of FPPH, also by cluster analysis, we tentatively assigned this patient the symbol (F)PPH. Among the overexpressed genes were genes coding for the following: notch homologue 3 (PϽ0.0001), cGMP-dependent protein kinase (PϽ0.0002), adenosine kinase (PϽ0.002), a large number of ribosomal proteins (altogether 26 of the 46 contained on the array), the gene encoding thioredoxin (PϽ0.006), cDNA topoisomerase II␣ (PϽ0.02), and the intracellular chloride channel 1 (PϽ0.02) (see also Figure  3B ). There were overall more clustered and nonclustered genes (Tables 2 and 3 and online data supplement available at http://www.circresaha.org), which showed more genes underexpressed than overexpressed (Figure 4 ). These underexpressed genes can be broadly categorized as genes coding for proteins involved in signal transduction (mitogen-activated protein kinase K7 [PϽ0.01]), cell cycle control (cyclindependent kinase 7), transcription and replication factors, binding proteins (fatty acid binding protein 3 and actin binding protein 278), enzymes (manosidase ␣ type II and alcohol dehydrogenase 5), and receptors (inositol 1,4,5-triphosphate receptor types 1, 2, and 3) 19 and Tek, which is involved in angiogenesis and vessel maintenance. 20 -22 The gene encoding gas 6 ("growth arrest-specific 6") was underexpressed in all 6 patients with PH ( Figure 4) . Surprisingly, cluster analysis demonstrated that the lung tissue gene expression pattern of the FPPH lungs resembled the pattern of the normal lungs more than it resembled the pattern expressed in sporadic PPH lungs, and there clearly were genes that were differently expressed in sporadic PPH when compared with FPPH lung tissue ( Figures 4B through  F) . Examples of these are the genes encoding a voltage-gated, shaker-related potassium channel; caspase 9 eukaryotic translation elongation factor 1␣ 23 ; the laminin receptor 1 24 ; the genes encoding an inward rectifying K ϩ channel; the endothelial PAS domain protein 1 25 ; the jun D proto-oncogene; and the gene encoding BMP4. 26 We confirmed the differences in gene expression between normal and PPH lung tissue for the following genes using quantitative polymerase Genes are listed in decreasing order of concordance. Affymetrix Probe Set number is the same as GenBank accession number. D indicates decreased expression; I, increased expression; and X, the number of concordant changes in sample comparisons of all 36 possible comparisons (6 PPH versus 6 normal).
chain reaction: ␤-actin, laminin receptor 1, and several homeobox genes 27 (data not shown).
Discussion
This is, to our knowledge, the first investigation, using gene array methodology, to conduct gene expression profiling of human lung tissues from patients with PH. PPH is a pathohistologically well-described disease, 1,4 -6,8 -10 and the pathognomonic microscopic precapillary arterial lesions are obvious and ubiquitously distributed throughout the entire lung and strictly confined to the lung vasculature. Although inflammatory cells, in particular macrophages and lymphocytes, are frequently increased in PPH lungs, 4 there is no interstitial or airway involvement in PPH. Because the vascular abnormalities are uniformly spread throughout the entire lung, one would expect that random lung tissue samples are representative of the entire lung. One potential limitation of our study is the relatively small number of patient tissues that were examined, because frozen lung tissue from PPH-and especially from FPPH patients suitable for RNA extraction-is rarely available. Although the number of patient samples was small, gene dendogram, cluster analysis, and concordant expression differences show that there are categorical and robust differences in the profile of expressed genes between structurally normal lungs, lungs from patients with PPH, and lungs from patients with FPPH. In our analysis, we chose to focus on statistically significant changes in the gene expression pattern and on the genes that demonstrated a high degree of concordance in their differential expression. As the number of differentially expressed genes is large, the number of concordantly expressed genes is relatively small. Although a certain number of altered genes represent expressed sequence tags and cannot at the present time be identified, our current study greatly expands the range of genes that are potentially of interest and have not been previously considered. In addition, gene expression profiling may be yet another method to distinguish PPH from FPPH.
Altered Pattern of Expressed Genes Related to Protein Synthesis and Degradation
The high concordance and clustering of genes encoding multiple components of large supramolecular complexes, which are likely organized by synexpression 28 such as the proteasome and the ribosomal machinery, and further the clustered differential expression of functionally related genes such as genes coding for ion channels, ubiquitin-conjugating enzymes, or genes coding for several mitochondrial proteins ( Table 3 ), indicate that the identified differences between normal and diseased lung tissue are real differences and do not represent procedural artifacts (see also online data supplement available at http://www.circresaha.org). We postulate that these differences in the pattern of overexpressed, underexpressed, and absent (nondetectable) genes between normal and diseased lung tissue can serve as a platform to further explore the relevant elements of the pulmonary hypertensive pathobiology. Abnormal cell growth and phenotypic alterations of pulmonary arterial endothelial and vascular smooth muscle cells are without doubt elements of the pathobiology of PPH. 6,9,29 Overexpression of genes coding for ribosomal proteins (Figure 3 ) and underexpression of genes coding for protein phosphatases (online data supplement available at http://www.circresaha.org) and coding for a variety of ion channels (Table 3, Figure 4 ) point toward a broad disturbance in protein synthesis, protein degradation, and altered vascular reactivity-certainly in keeping with dysfunctional vascular endothelial and smooth muscle cell phenotypes. The proteasome is an essential component of the ATP-dependent proteolytic pathway leading to the complete breakdown of proteins to small peptides, elimination of abnormal proteins, and generation of antigenic peptides that are being presented on major histocompatability class I molecules to lymphocytes. 30, 31 The ubiquitin-proteasome-mediated proteolysis is also an important mechanism that controls the destruction of cellular regulatory proteins including the cyclins, p27, the transcription factor E2F, and the receptors for epidermal growth factor and platelet-derived growth factor. 30 
Altered Pattern of Genes Expressed in Muscle and Endothelial Cells
The abnormal vascular cell phenotype may be related to the decreased expression of several cytoskeletal and extracellular matrix proteins. Genes involved in the control of endothelial cell biology are differentially expressed between PPH and normal lung. For additional details, see the online data supplement available at http://www.circresaha.org.
Altered Pattern of Genes Involved in Cell Growth and Apoptosis
Our decision to restrict this first gene microarray study of PH to lung tissue from patients with PPH was guided by our bias that patients with secondary PH constitute a less homogenous group and by our knowledge that endothelial cell proliferation in sporadic PPH is monoclonal, but polyclonal in secondary PH, 32 and that the monoclonal endothelial cell growth may mechanistically differ from the endothelial cell growth in secondary PH. 13 Because the lumen-obliterating endothelial cell growth in sporadic PPH shares features with a neoplastic process, ie, microsatellite instability and mutations in the TGF-␤RII and Bax genes, 13 we wondered whether the microarray analysis would shed further light on this postulated mechanism. Although the lung tissue gene expression pattern analysis cannot provide mechanistic evidence for such a hypothesis, it perhaps provides additional, unexpected information in support of a neoplasia-like cell growth program and molecular information that transcends the description of altered pulmonary vascular cell phenotypes. Cell growth in PPH lungs may be facilitated by altered expression of cell cycle-and apoptosis-regulating genes. We recently found that there are fewer terminal deoxynucleotidyltransferase-mediated dUTP nick-end labeling (TUNEL)-positive cells in lung tissue samples from PPH patients when compared with normal adult lung tissue samples and that there is an absence of TUNEL-positive cells in the plexiform lesions. 33 In this context, it is of interest that the gene encoding the inositol 1,4,5-triphosphate receptor type III, which is involved in apoptosis regulation, 19, 34 was decreased in its expression in all of the PH lung tissues (Table 3) and that the gene encoding caspase 9 was at a very low expression level in the 3 sporadic PPH patient lungs. On the other hand, the gene encoding "defender of cell death" (DAD1), which when lost triggers apoptosis, was decreased in PPH (Table 3) .
The following findings could further support a neoplasialike paradigm of sporadic PPH 35 : the decreased expression of the gene coding for gas 6, the thyroid receptor interactor (PϽ0.008) (nuclear receptor) that interacts with the cAMP response element binding protein; a decrease in the expression of the gene encoding the DNA repair gene (mapped to the human chromosome 2q25 locus) KU80 36 in all 6 PH tissue samples together with an overexpression of the laminin receptor 1 gene 37 ; and a decreased expression of the gene coding for the eukaryotic translation elongation factor 1␣ 1 in sporadic PPH lung tissue (Figure 4 ).
Altered Pattern of Expressed Genes in FPPH
As stated above, we found that the gene expression pattern of patient 6 more closely resembled the expression pattern of the 2 patients with known FPPH and further that several genes were differentially expressed in the tissues of the FPPH patients and the (F)PPH patient when compared with PPH lung tissue (Figures 3 and 4) . In fact, it is surprising how different the lung tissue gene expression in sporadic PPH is when compared with FPPH. When we explored whether expression differences would exist in 14 genes localized to the FPPH chromosomal gene site (2q31 to 2q32) 38 and compared PPH and FPPH samples, no statistically significant differences were found. However, there were a number of other genes that were found to be highly significantly different in their expression when PPH and FPPH/ (F)PPH lungs were compared. Increased in sporadic PPH versus FPPH were the genes encoding the following: apolipoprotein CIII (PϽ0.0002), 5-hydroxytryptamine receptor 1B (PϽ0.0002), BMP4 (PϽ0.005), cathepsin D (PϽ0.001), serum response factor 39 -41 (PϽ0.01), ␣ 2 -macroglobulin (PϽ0.0008), jun D proto-oncogene (PϽ0.0007), laminin receptor 1 (PϽ0.004), and caspase 9 (PϽ0.002). Decreased in PPH versus FPPH were the following: interleukin enhancer binding factor I (PϽ0.001); the gene encoding a voltage-gated, shakerrelated K ϩ channel; and the genes coding for TGF-␤RII, Smad1 26, [42] [43] [44] (Table 4) , and BMP-2 (see also online data supplement available at http://www.circresaha.org).
Conclusion
We began our study of differential gene expression in PPH with the assumption that sporadic PPH is a disease with typical and dramatic histological features, which are sufficiently distinct from those of the structurally normal lung but essentially indistinguishable from those found in FPPH lungs. We expected that, when we compared normal and PH lung tissue, there would be a very large number of differentially expressed genes, and we found this to be true. But we were surprised to find that only 307 genes were significantly different in their expression when PH tissues were compared with structurally normal lung tissues. The microarray analysis of whole lung tissue samples is useful, because it revealed a clear signature pattern of expressed genes in patients with sporadic PPH and FPPH. A large group of genes encoding ribosomal, mitochondrial, and cytoskeletal proteins and genes encoding ion channels and enzymes were differentially expressed between PH and normal lungs. Several transcription factor genes and genes related to cyclin-dependent kinases were different in their expression, indicating, in the aggregate, that the PH gene signature reflects a profound imbalance in the control of genes involved in cell proliferation and apoptosis. Although the beneficial treatment and survival effect that has been reported for PPH patients treated with prostacyclin 45, 46 could well be associated with increased or repressed expression of one or several genes, prostacyclin treatment was not a variable that accounted for the difference in the gene expression profile between sporadic PPH and FPPH.
Our study was conducted using total RNA extracted from random lung tissue samples; we did not include for analysis information that is based on the exploration of lasermicrodissected plexiform lesions, but we did compare mRNA and total RNA from the same samples. We found that the analysis of lung tissue mRNA provides less information than the analysis of total RNA samples (see online data supplement available at http://www.circresaha.org). However, our work presented here and conducted with whole-tissue total RNA indicates that there are striking differences in the molecular expression profiles between sporadic and familial PPH. These differences in expression profiles are complemented by independent gene mutation analysis. Only the plexiform lesions in the lungs from patients with sporadic PPH 13 but not from FPPH lungs display mutations of the Bax and TGF-␤ RII genes (M. Yeager, unpublished data, 2001 ). Taken together, the RNA expression data and the DNA mutation data 13 lead to the conclusion that sporadic and familial PPH are mechanistically distinct. 
